Delivery Order SPE2DB22D2206-SPE2DB25FJG49
Award Date 8/6/25
Potential Completion Date 8/27/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5.7 million to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a pharmaceutical product used in cancer treatment. This firm fixed price, non-set-aside delivery order was awarded on May 12, 2025, with completion expected by June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as a child contract...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract type. The delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply transaction. This delivery order is...
- AmerisourceBergen Drug Corp received a firm fixed price delivery order valued at $5,704.45 from the Defense Logistics Agency (DLA) for 120 tablets of Bosulif 100 mg, a targeted cancer therapy medication. Awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, this non-set-aside contract represents a competitive award to support federal medical procurement needs. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Bosulif 400 mg tablets (30-count packages) valued at $11,815.63. The contract is not set-aside and represents a competitively awarded order with an ultimate completion date of October 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $23,631.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a non-competitive, non-set-aside procurement. The order, issued on September 9, 2025, with completion targeted for September 30, 2025, represents a single delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count) on August 21, 2025, with completion expected by September 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract, utilizing no set-aside designation, represents a competitive award under the company's broader pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a ceiling value of $11.4K. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price contract, awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Bosulif is a prescription oncology...
- The Defense Logistics Agency awarded a delivery order valued at $5.7K to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a tyrosine kinase inhibitor used in oncology treatment. The contract was competitively awarded without set-aside provisions under firm fixed pricing terms, with performance at the vendor's Conshohocken, Pennsylvania location and an ultimate completion date of August 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...